Tyrosinase-related oculocutaneous albinism (OCA1), an autosomal recessive inborn error of pigmentation, is caused by the deficiency of tyrosinase. We had previously identified two different mutations of the TYR gene in a four year old Korean male with mild OCA; a P310insC frameshift in exon 2 and an IVS2--7t-~a,--10--1 ldeltt splice junction mutation in exon 3. Here we report a prenatal diagnostic study of a subsequent fetus of the above family that was at 25% risk of OCA1. SSCP/heteroduplex screening, restriction enzyme digestion, and allele-specific oligonucleotide hybridization analyses of DNA obtained by chorionic villus sampling indicated that the fetus was a compound heterozygote for the paternal P310insC and the maternal IVS2-7t--*a,-10--I ldeltt mutations. The diagnosis was later confirmed by observation of poorly pigmented irides of the abortus terminated at the 18th week of gestation. This approach provides a fast and reliable method for DNA-based prenatal diagnosis when specific mutations are known in families at high risk of OCAI.
INTRODUCTION
Oculocutaneous albinism (OCA) is an autosomal recessive genetic disorder characterized by deficient biosynthesis of melanin pigment in the skin, hair follicle, and eyes (Witkop et aL, 1989; Spritz, 1994; Spritz and Hearing, 1994) . Patients affected with OCA typically exhibit reduced visual acuity with nystagmus, strabismus, and photophobia, and extremely fair skin complexion with a high risk of skin cancers due to actinic damage. In addition, OCA patients are often socially handicapped due to their appearance, especiaIly in non-Caucasian populations. The prevalence of OCA is about 1 per 16,000-20,000 individuals in the United States (Witkop et al., 1989) and in Japan (Shimizu et aL, 1994a) .
Several types of OCA have been described, resulting from mutations in three distinct loci; OCAI is associated with the TYR gene (Tomita et al., 1989; Spritz, 1994) , OCA2 is associated with the P (pink-eyed dilution) gene (Rinchik et al., 1993; Lee et aL, 1994) , and OCA3 is associated with the TYRP-1 gene (Boissy et al., 1996) . Among these, OCAI is associated with deficient activity of melanocyte tyrosinase which catalyzes the rate-limiting steps of the melanin biosynthesis (Lerner and Fitzpatrick, 1950; Lerner el al., 1949; Tripathi et aL, 1992) . In OCAIA (tyrosinase-negative OCA1), tyrosinase activity is completely absent (Tripathi et aL, 1992; Tomita et aL, 1989) , whereas in OCA1B (yellow OCA1) tyrosinase activity is greatly reduced (Giebel et aL, 1991a) . OCAIB thus tends to be clinically less severe than OCAIA, though there is virtual overlap between the associated clinical phenotypes. Prenatal diagnosis of OCA has been accomplished by evaluating fetal skin obtained by biopsy (Eady et al., 1983; Eady, 1984; Gershoni-Baruch et aL, 1991; Shimizu et aL, 1992 Shimizu et aL, , 1994b or by analyzing the TYR gene in fetal DNA obtained by aminiocentesis (Shimizu et aL, 1994a; Falik-Borenstein et al., 1995) .
We have recently identified six different mutations of the TYR gene in the 9 Korean patients with OCAI (Park et aL, 1996; Park et aL, 1997) . One of these patients exhibited OCAIB associated with a P310insC frameshift (CCA--,CCCA) and an IVS2--7t---,a,--10--1 ldeltt splice junction mutation (tttttaatgaacagGA--, tttaaagaacagGA) of the TYR gene (Park et aL, 1997) . Recently, this patient's parents requested prenatal diagnosis for their second pregnancy. Here, we report the diagnosis of OCAIB in that fetal sample, obtained by chorionic villus sampling (CVS) at 10th week of gestation. This approach provides a fast, safe, and reliable method for prenatal diagnosis at a very early stage in gestation in families at elevated risk for OCAt and other genetic disorders.
MATERIALS AND METHODS

Chorionic villus sampling.
A Korean couple had a 4-year-old son with OCA1B. Molecular analysis of the TYR gene demonstrated that the proband was a compound heterozygote for a P310insC frameshift in exon 2 and an IVS2--7t--, a,--10---11deltt splice junction mutation in adjacent to exon 3 (Park et aL, 1997) . The mother was in her second pregnancy and was referred for prenatal diagnosis of OCA. For prenatal diagnosis, CVS was performed at the 10th week of gestation and the fetal tissue was dissected to remove maternal decidua.
PCR amplification of the human TYR gene. Genomic DNA was isolated from the CVS sample and from peripheral-blood leukocytes of the proband, the parents, and unrelated normal controls (Sambrook et aL, 1989) . The TYR exon 2 and 3 segments containing the TYR mutations in the proband were amplified from the genomic DNAs by the polymerase chain reaction (PCR) using as primers 5"-CCTCAGGAGAAGTCTAACAAC-Y/5'-ACAACACATATTCTTGGTC-3' (exon 2) and 5"-TGGGTATCCAGAATGTAAA-Y/5"-TTTAAATCCAATGA-GCACG-Y (exon 3) (Giebel et al., 1991b; Park et al., 1997) and Taq DNA polymerase (Perkin Elmer, USA) as described (Saiki et al., 1988; Park et al., 1997) .
DNA-based prenatal diagnosis. The amplified exon segments were analyzed by two different methods. First, the presence of the specific mutations in fetal sample was tested by non-radioactive simultaneous analyses of SSCPs and heteroduplexes (Lee et al., 1995) using MDE gel (FMC BioProducts, USA).
Heterozygosity for the P310insC frameshift was confirmed by allele-specific oligonucleotide (ASO) hybridization (Saiki et al., 1986) . Two hundred nanograms of the exon .2 PCR products were applied to a nylon membrane (Micron Separation Inc., USA) using a slot blot apparatus (Hoefer Scientific Instrument, USA). Nineteen-mer oligonucleotides including the normal P310 (5'-CCAGACCCCAA-GGCTCCC-Y) and mutant P310insC (5'-CCAGAACCCCCAAGGCTCC-Y) were labeled at the 5'-end by T4 polynucleotide kinase. The nylon membranes were prehybridized and hybridized at 37°C in 5 × SSPE, 5 x Denhardt's solution, and 0.5% SDS, and washed at 60°C in 3 M tetramethylammonium chloride, 50 mM Tris-HC1 (pH 8.0), 2 mM EDTA, and 0.1% SDS before autoradiography.
The IVS2--7t-+a,--10---1 ldeltt mutation generates a novel DraI restriction enzyme cleavage site. Heterozygosity for this mutation was thus confirmed by DraI digestion of the exon 3 PCR products and electrophoresis in 5% polyacrylamide gel.
RESULTS AND DISCUSSION
We have carried out prenatal diagnosis of OCA in the pregnancy of parents with a previous child with OCA1B resulting from compound heterozygosity for a P310insC frameshift and a splice junction mutation, IVS2-7t-+a,-10---lldeltt (Park et al., 1997) . The risk of the OCA1B in the fetus was 25%. We utilized two different DNA-based approaches to detect each mutation.
The presence of the P310insC mutation in the fetal sample was first determined by SSCP/heteroduplex analysis of the TYR exon 2 PCR products. The sample from the proband who was heterozygous for the P310insC mutant allele demonstrated an aberrant band in the fast-migrating duplex region (Fig. 1A) . The abberrant band was also detected in the lanes of the father and the fetus, but not in the lane of the mother (Fig. IA) . The fetus was thus heterozygous for a paternal P310insC mutant allele. Fig. 1 . Analysis of the P310insC frameshift (A) and the IVS2t-~a,-10---lldeltt mutation (B) by simultaneous SSCP and heteroduplex detection. Lanes C, a normal control; F, the father; M, the mother; P, the proband affected with OCAIB; S, the fetal sample under study. A heteroduplex band characteristics of the P310insC frameshift is marked as an arrowhead in the A panel. An SSCP band and heteroduplex bands characteristics of the IVS2t-~,a, -10---ltdeltt mutation are marked as an arrow and arrowheads in the B panel, respectively.
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Heterozygosity for the P310insC frameshift in the fetus was further determined by ASO hybridization analysis using the P310 normal and the P310insC mutant oligonucleotides. As shown in Fig. 2 , the exon 2 PCR products from the father, the Fig. 2 . Analysis of the P310insC frameshift by ASO hybridization. The upper panel and the lower panel show slot blot hybridization with the probes specific for the sequence containing the P310insC frameshift (Mutant) and for the normal sequence (Normal), respectively. Lanes C-S, same as lanes in Fig. 1 .
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proband, and the fetus were hybridized with both mutant and normal oligonucleotides, whereas the exon 2 PCR products from the mother and a normal control were hybridized only with the normal oligonucleotide. The fetus was thus confirmed to be heterozygous for the P310insC frameshift. The presence of the IVS2-7t-~a,--10---1 ldeltt mutation in the fetal sample was also determined by SSCP/heteroduplex analysis of the TYR exon 3 PCR products. The sample from the proband who was heterozygous for the IVS2-7t--+ a,--10---lldeltt mutant allele demonstrated aberrant bands in both slowmigrating single-strand and fast-migrating duplex regions (Fig. 1B) . The abberant bands were also detected in the lanes of the mother and the fetus, but not in the lanes of the father and a normal control (Fig. I B) . The fetus was thus heterozygous for a maternal IVS2--7t~a,--10---1 ldeltt mutant allele.
Because the IVS2-7t~a,-I0---1 ldeltt splice junction mutation generates a novel DraI restriction enzyme site, heterozygosity for the IVS2--7t-,a,-10---1 ldeltt mutation in the fetus was further determined by digestion with restriction enzyme DraI. Whereas the 356-bp exon 3 PCR products from the father and a normal control were not cleaved by DraI digestion, a half amount of the exon 3 PCR products from the mother, the proband, and the fetus were cleaved to the 202-bp and 152-bp fragments (Fig. 3) . The fetus was thus confirmed to be heterozygous for the IVS2--7t--,a,--10---1 ldeltt mutation.
Because we obtained consistent results in two independent analyses for each TYR mutation, we concluded that the fetus was a compound heterozygote for the P310insC frameshift and the IVS2-7t~a,-10---1 ldeltt splice junction mutation. Therefore, the fetus was expected to exhibit OCA1B as same as the proband. The 
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Analysis of the IVS2t~a,--10--lldeltt mutation by Dral digestion. The IVS2t-->a,--10---1 ldeltt mutation generates a DraI site. By Dral digestion, the 354~bp mutant exon 3 allele cleaves to the 202-bp and 152-bp fragments but the 356-bp normal exon 3 allele remains intact. Lanes C-S, same as lanes in Fig.  1 ; m, a molecular size marker (Gibco BRL Life Technologies Inc.). parents decided to terminate the prenancy at the 18th week of gestation. The prenatal diagnosis was confirmed by observation of poorly pigmented irides of the abortus.
We have shown that OCA1 can be diagnosed using fetal cells obtained by CVS at the 10th week of pregnancy using simple DNA-based approaches such as non-radioactive simultaneous SSCP/heteroduplex analysis, restriction enzyme cleavage, and ASO hybridization. These results would provide a fast and accurate procedure for prenatal diagnosis of OCA1 and other genetic diseases.
